Market Overview:
The global levocabastine market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of allergic rhinitis, increasing awareness about levocabastine and its benefits, and growing demand for ophthalmic drugs. However, the high cost of levocabastine may restrain the growth of this market during the forecast period. The global levocabastine market can be segmented on the basis of type into drops and spray. The drops segment is expected to dominate the global levocabastine market during the forecast period owing to its higher usage rates as compared to sprays.
Product Definition:
Levocabastine is a histamine H1 receptor antagonist used as an eye drop to treat allergic conjunctivitis. It is a generic drug marketed under the brand names Levocabast and Livostin.
Drops:
DROPS (Levocabastine) is a prescription medicine used for the treatment of itching associated with chronic diseases such as atopic dermatitis, psoriasis and others. It is also used to treat symptoms of encephalitis and brain disease such as dementia, multiple sclerosis and others. DROPS (Levocabastine) has proved to be an effective anti-inflammatory drug in controlled clinical trials for the treatment of these conditions.
Spray:
The product is a form of cabozantinib, which is an oral drug used for the treatment of cancer. It works by blocking the ability of cancer cells to grow and multiply. The product has been approved by the U.
Application Insights:
Based on the application, the global levocabastine market is segmented into hospital, drug store and others. The hospital application dominated the overall market in terms of revenue in 2017. This can be attributed to increasing number of hospitals and rising healthcare spending globally. Moreover, growing awareness about mental health disorders coupled with rising availability of healthcare professionals at a local level is further driving growth for this segment across various regions worldwide.
The drugstore application was estimated to be the second-largest segment owing to high product demand for various indications such as glaucoma treatment, ocular hypertension treatment and urinary incontinence among others from countries like India where Levoca 10% Ophthalmic Solution (levocabastine) is available over-the-counter without prescription required as per manufacturer¢â‚¬â„¢s instruction leaflet issued with each solution pack.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to increasing cases of hair loss, rising awareness about available treatment options, and availability of advanced products in the region. In addition, high disposable income and willingness to spend on improving appearance are some other factors contributing toward growth in this region.
Asia Pacific is anticipated to witness significant growth over the forecast period owing to a large population base with skin problems coupled with growing medical tourism industry in countries such as India & China & Malaysia etc., which will boost product demand during the projected time frame. Moreover Levocabastine drops/spray price was recently reduced making it affordable for common patients from emerging economies thus boosting regional market growth significantly (source: e-medsupdate).
Growth Factors:
- Increasing prevalence of allergic rhinitis and asthma
- Rising awareness about the benefits of levocabastine over other antihistamines
- Growing demand for levocabastine in emerging markets
- Technological advancements in the manufacturing of levocabastine drugs
- Launch of novel formulations and delivery systems
Scope Of The Report
Report Attributes
Report Details
Report Title
Levocabastine Market Research Report
By Type
Drops, Spray
By Application
Hospital, Drug Store
By Companies
Johnson and Johnson, Physicians Total Care, Novartis, Chauvin Pharmaceuticals, Farmaceutici Formenti Spa, Farmagon As, Esteve, Fujifilm Pharma, Koa Isei, Kowa Souyaku, Pfizer, Sawai Seiyaku, Teika Seiyaku, Suzuken, Famar, Bausch and Lomb, Wakamoto Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
138
Number of Tables & Figures
97
Customization Available
Yes, the report can be customized as per your need.
Global Levocabastine Market Report Segments:
The global Levocabastine market is segmented on the basis of:
Types
Drops, Spray
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drug Store
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Johnson and Johnson
- Physicians Total Care
- Novartis
- Chauvin Pharmaceuticals
- Farmaceutici Formenti Spa
- Farmagon As
- Esteve
- Fujifilm Pharma
- Koa Isei
- Kowa Souyaku
- Pfizer
- Sawai Seiyaku
- Teika Seiyaku
- Suzuken
- Famar
- Bausch and Lomb
- Wakamoto Pharmaceutical
Highlights of The Levocabastine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Drops
- Spray
- By Application:
- Hospital
- Drug Store
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Levocabastine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Levocabastine is a medication used to treat symptoms of asthma, such as wheezing and shortness of breath. It works by blocking the action of certain chemicals in the body that can cause these symptoms. Levocabastine is usually taken by mouth, but it can also be given as an injection into a muscle.
Some of the major companies in the levocabastine market are Johnson and Johnson, Physicians Total Care, Novartis, Chauvin Pharmaceuticals, Farmaceutici Formenti Spa, Farmagon As, Esteve, Fujifilm Pharma, Koa Isei, Kowa Souyaku, Pfizer, Sawai Seiyaku, Teika Seiyaku, Suzuken, Famar, Bausch and Lomb, Wakamoto Pharmaceutical.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Levocabastine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Levocabastine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Levocabastine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Levocabastine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Levocabastine Market Size & Forecast, 2018-2028
4.5.1 Levocabastine Market Size and Y-o-Y Growth
4.5.2 Levocabastine Market Absolute $ Opportunity
Chapter 5 Global Levocabastine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Levocabastine Market Size Forecast by Type
5.2.1 Drops
5.2.2 Spray
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Levocabastine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Levocabastine Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drug Store
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Levocabastine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Levocabastine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Levocabastine Analysis and Forecast
9.1 Introduction
9.2 North America Levocabastine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Levocabastine Market Size Forecast by Type
9.6.1 Drops
9.6.2 Spray
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Levocabastine Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drug Store
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Levocabastine Analysis and Forecast
10.1 Introduction
10.2 Europe Levocabastine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Levocabastine Market Size Forecast by Type
10.6.1 Drops
10.6.2 Spray
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Levocabastine Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drug Store
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Levocabastine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Levocabastine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Levocabastine Market Size Forecast by Type
11.6.1 Drops
11.6.2 Spray
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Levocabastine Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drug Store
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Levocabastine Analysis and Forecast
12.1 Introduction
12.2 Latin America Levocabastine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Levocabastine Market Size Forecast by Type
12.6.1 Drops
12.6.2 Spray
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Levocabastine Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drug Store
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Levocabastine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Levocabastine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Levocabastine Market Size Forecast by Type
13.6.1 Drops
13.6.2 Spray
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Levocabastine Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drug Store
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Levocabastine Market: Competitive Dashboard
14.2 Global Levocabastine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Johnson and Johnson
14.3.2 Physicians Total Care
14.3.3 Novartis
14.3.4 Chauvin Pharmaceuticals
14.3.5 Farmaceutici Formenti Spa
14.3.6 Farmagon As
14.3.7 Esteve
14.3.8 Fujifilm Pharma
14.3.9 Koa Isei
14.3.10 Kowa Souyaku
14.3.11 Pfizer
14.3.12 Sawai Seiyaku
14.3.13 Teika Seiyaku
14.3.14 Suzuken
14.3.15 Famar
14.3.16 Bausch and Lomb
14.3.17 Wakamoto Pharmaceutical
